Dr. Dorothea Altschul is a Columbia- and Harvard-trained neurovndovasculaar surgeon and Director of Neuroendovascular Surgery and Clinical Neurosciences at The Valley Hospital. Her work focuses on cerebrovascular disease, with over a decade of data showing exceptional outcomes at the Valley Hospital. Recognized as a top doctor in her field, she’s passionate about advancing our understanding of venous brain disorders, pulsatile tinnitus, and brain pressure–related syndromes, and about translating that science into real solutions for patients.

Thomas C Booth is a Reader in Neuroimaging at King’s College London and an Interventional Neuroradiologist at King’s College Hospital. His work in interventional neuroradiology focuses on the development of robotics to enhance precision and safety in endovascular interventions – here he integrates artificial intelligence into navigation. His PhD was at the University of Cambridge where he first learnt about AI before the days of deep learning. He is now the UK Neurovascular Group research lead, as well as the AI Faculty lead at the Royal College of Radiologists. He has led multiple UK multicentre studies including the largest neurology study in the UK which recruited 37,000 prospective patients. He is  an active contributor to national and international committees and is an awardee of the Royal College of Radiologists Outstanding Researcher Award.

Dr. Grandhi is a cerebrovascular neurosurgeon who currently serves as the Neuroendovascular Section Chief and Fellowship Director. He is a Professor of Neurosurgery at the University of Utah and is Surgical Co-Director of the University of Utah Stroke Center.

Dr. Brian Hoh is the James and Brigitte Marino Family Professor and Chair of the Lillian S. Wells Department of Neurosurgery at the University of Florida, where he also serves as Chief of Medical Staff for UF Health Shands.

He is an NIH-funded investigator.  He is past President of the Congress of Neurological Surgeons, past Chair of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Cerebrovascular Section, and currently serves on the Board of Directors of the American Board of Neurological Surgery. He has served as co-chair of the Editorial Board of the Journal of Neurosurgery.

Dr. Hoh received his B.A.S. from Stanford University, his M.D. from Columbia University, and completed his neurosurgery residency and interventional neuroradiology fellowship at Massachusetts General Hospital. He received his M.B.A. from the University of Florida.

Brian Jankowitz is currently the Chief of Neurosurgery at JFK University Medical Center in Edison, NJ.  He previously served as the head of Cerebrovascular Neurosurgery at the University of Pennsylvania.  Dr. Jankowitz trained at the University of Pittsburgh where he completed his internship, residency, and fellowship in NeuroEndovascular Surgery.  He distinguished himself with his early interest in ischemic and hemorrhagic stroke, having taken part in every major U.S. interventional stroke trial.  His current focus is on novel mechanisms of ICH evacuation. He is also the national PI for the SEAL-IT trial, which is evaluating a new intra-saccular aneurysm occlusion device.

Professor Neurosurgery Wake Forest University

Director of Cerebrovascular Program, Neurosurgery
Surgical Director of the Stroke Network, AdvocateHealth
Advocate Lutheran General Hospital | Advocate Illinois Masonic Medical Center

Medical Director, Advanced Neuroendovascular Surgery IRCAD NA

Prof. Pedro Lylyk, MD, is a world-renowned leader in endovascular neurosurgery and currently serves as the Director and CEO of ENERI and Clínica La Sagrada Familia in Buenos Aires, Argentina. A graduate of the University of Buenos Aires (UBA), he completed his residency in Pediatric Neurosurgery at the Ricardo Gutiérrez Children’s Hospital before pursuing specialized fellowships in Canada (University of Western Ontario) and the United States (UCLA). His extensive academic career includes serving as Chair of Neurosurgery and Hemodynamics at the Faculty of Medicine of the Universidad de Buenos Aires (UBA), where he directs Master’s programs in Neuroradiology, as well as holding professorships at the Universidad del Salvador (USAL) and the Universidad de Ciencias Empresariales y Sociales (UCES). An undisputed pioneer, he performed the first intracranial stent placement in 1996, a milestone in a clinical practice that exceeds 10,000 treated aneurysms and arteriovenous malformations. Throughout his career, he has founded key institutions such as the FENERI Foundation, the Cerebrovascular Research and Educational Foundation (CREF), the Swiss Neurofoundation, the Intracranial Stent Meeting the World Life Neurovascular Conference (WLNC), while presiding over prestigious organizations including the Argentine Stroke Association (AAAC), the Iberolatinoamerican Society of Diagnostic and Therapeutic Neuroradiology

(SILAN) and others. His contributions have been honored with numerous awards, such as “Outstanding Personality of Science,” the 2022 National Academy of Medicine Award for AI in stroke research, and the 2024 Innovators in Cerebrovascular Science Award. “He was awarded the title of Doctor Honoris Causa by the University of Buenos Aires in late 2025, in recognition of more than four decades of innovation in endovascular neurosurgery and his significant impact on stroke treatment.” In addition to his clinical work, he leads the National Stroke Prevention Campaign and directs one of the region’s premier international training centers, having mentored over 150 professionals from across the globe.

Shahram Majidi, MD, is an Associate Professor of Neurosurgery at the Icahn School of Medicine at Mount Sinai and Director of the Neuroendovascular Surgery Fellowship. He serves on the Board of Directors of the Society of NeuroInterventional Surgery (SNIS) and as Vice Chair of the Guidelines Committee of the Society of Vascular and Interventional Neurology (SVIN). As Principal Investigator of the COMMAND trial, he performed the first endovascular brain–computer interface (BCI) implantation in the United States in 2022. His clinical and research expertise focuses on advanced endovascular treatments for cerebrovascular disease, brain aneurysms, stroke thrombectomy techniques, and cortical vein navigation.

Dr Adnan I. Qureshi is a Professor of Clinical Neurology and Program Director, Endovascular Surgical Neuroradiology Fellowship at the University of Missouri School of Medicine. He is also the Executive Director of Zeenat Qureshi Stroke Institutes (ZQSI). He has written over 890 scientific publications in prestigious journals and 14 text books. He has served in several leadership positions in clinical trials pertaining to interventional neurological procedures and stroke and has received several prestigious awards at the national and international level.

Dr. Eric Peterson is a physician-entrepreneur based in Miami and a vascular neurosurgeon by training, with deep experience building and scaling medical device companies. In 2018, he founded RIST Neurovascular, a company focused on catheter systems for radial access to the cerebral vasculature, and led it from concept through FDA clearance and acquisition by Medtronic in 2020.

In 2021, he founded Hyperion Surgical where he leads development of a robotic vascular access system.  The system integrates AI vessel recognition, robotic automation, and full catheter placement to deliver surgeon-level vascular access by an on-site technician in under five minutes, with expert-in-the-loop remote supervision through live imaging and telemetry.  His work sits at the intersection of robotics, artificial intelligence, clinical medicine, and scalable device commercialization.

Marc Ribó is an interventional neurologist at Hospital Vall d’Hebron in Barcelona, specializing in acute stroke care and endovascular treatments. His work focuses on regional stroke networks, advanced neuroimaging, neuroprotection and the development of innovative thrombectomy devices. He is the founder of Anaconda Biomed and has led multiple translational research projects bridging clinical needs with medical device innovation.

Edgar A. Samaniego, MD, MS is a Clinical Professor of Neurology, Neurosurgery, and Radiology at the University of Iowa. He serves as Director of the Vascular Neurology Fellowship. Dr. Samaniego specializes in cerebrovascular diseases, with a focus on intracranial aneurysms, advanced neurovascular imaging, and endovascular therapies. His research centers on multiparametric MRI, aneurysm wall imaging, radiomics, and device-based innovation in neurointervention. He has authored more than 300 peer-reviewed publications and has received funding from foundations and industry partners. Nationally and internationally, he is active in clinical trials, guideline development, and professional societies, and is deeply committed to mentorship, fellowship education, and advancing patient-centered stroke care.

Dr. Fifi is a Professor of Neurology, Neurosurgery, and Radiology at the Icahn School of Medicine at Mount Sinai. She is also Associate Director of the Cerebrovascular Center, Director of Cerebrovascular Services at Mount Sinai Hospital, and Director of the Pediatric Cerebrovascular Program. She is Immediate Past President of the Society of Neurointerventional Surgery, past board member of the Society of Vascular and Interventional Neurology, and a past committee chair of the US accrediting body for Neuroendovascular Surgery Fellowships. She has led a number of clinical research trials into adult and pediatric cerebrovascular disease and stroke systems of care. Dr. Fifi has authored over 200 publications and is an associate editor of the Stroke: Vascular and Interventional Neurology Journal. Dr. Fifi specializes in the endovascular treatment of cerebrovascular disorders including vein of Galen malformation, arteriovenous malformations and fistulas of the brain and spine, stroke, brain aneurysms, intracranial and carotid stenosis, as well as craniofacial vascular lesions in children and adults.

Dr. Carlos Peña is Chief Regulatory Officer and Chief Quality Officer, leading the Offices of Regulatory Services and Office of Quality Services, at the Jacobs Institute (JI) in Buffalo, New York. Dr. Peña is also Chief Executive Officer of a private consultant firm just outside the Washington DC area where he advises small-, medium-, and large-sized companies on medical product FDA regulation and review. Prior to his current work, Dr. Peña served 20+ years as a public servant in federal government, including Director of the Office of Neurological and Physical Medicine Devices, at the Center for Devices and Radiological Health (CDRH), at the U.S. Food and Drug Administration (FDA), based in the Washington, DC area. He was responsible for providing leadership in the development of safe and effective neurological and physical medicine devices to support FDA’s mission. Specifically, he provided oversight over several cross-functional teams and was the lead contact for the agency’s strategic plans and implementation efforts for neurological, physical medicine, diagnostics, and rehabilitative devices. Before his FDA Director role, Dr. Peña served as Assistant Director of Emerging Technologies in the White House Office of Science & Technology Policy (OSTP) in the Executive Office of President Obama for two years (2012-2014). Dr. Peña holds a PhD in Neuroscience from Case Western Reserve University, Masters degree in Comparative Physiology from the University of Connecticut, and Bachelor of Science from the City College of New York.

Ansaar Rai is Professor and Chair of Neuroradiology at the Rockefeller Neuroscience Institute, West Virginia University, Morgantown, and Chief Medical Officer for Siemens Healthineers Endovascular Robotics. Experienced neurointerventionalist with leadership in clinical trials, translational research, and physician–industry collaboration spanning device development, evaluation, and clinical adoption.

Dr. Fiorella has worked extensively on MMA based therapies, including acting as co-PI( for the recently published STEM trial of MMA embolization for cSDH. He has also worked extensively on the IA lidocaine infusions for refractory migraine headache. He and Dr. Arthur are leading a future trial to evaluate MMA embolization for refractory migraine.

Dr. Burkhardt is currently the Division Head of Cerebrovascular and Neurointerventional Surgery at the University of Pennsylvania in Philadelphia (Penn Medicine). He is dual fellowship trained in both endovascular and open techniques and is currently The James and Agnes Kim Assocciate Professor of Neurosurgery.

Luis Savastano M.D. Ph.D. is an academic surgeon-scientist at the University of California San Francisco (UCSF). He is a hybrid cerebrovascular neurosurgeon with a busy microsurgical and endovascular practice, and the Principal Investigator of the UCSF Transcatheter Neurosurgical Technologies Lab, where a multidisciplinary team executes trailblazing translational research and state-of-the-art technology development.

Dr. Aquilla Turk is a neuroendovascular surgeon in Greenville, South

Carolina and is affiliated with Prisma Health-Greenville Memorial
Hospital since 2018. He previously had a busy academic and clinical
practice at the University of Wisconsin and Medical University of South
Carolina. He completed a fellowship in diagnostic and interventional
neuroradiology at the University of Wisconsin in 2002. He remains
clinically active in all aspects of endovascular treatment of
cerebrovascular diseases with current professional focus in robotic surgery.

He was the Chief Medical Officer for Corindus
Robotics and currently is the CMO for Imperative Care. He has run
several large clinical trials including the COMPASS and POSITIVE
trials.